Adiponectin, leptin, nitric oxide, and C-reactive protein levels in kidney transplant recipients: comparison with the hemodialysis and chronic renal failure

References

• Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 1998;9:16–23.
   PubMed Web of Science ®Google Scholar
• Kasiske BL. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med. 1988;84:985–992.
   PubMed Web of Science ®Google Scholar
• Fort J. Chronic renal failure: A cardiovascular risk factor. Kidney Int. 2005;99:25–29.
   Google Scholar
• Vlagopoulos PT, Sarnak MJ. Traditional and nontraditional cardiovascular risk factors in chronic kidney disease. Med Clin N Am. 2005;89:587–611.
   PubMed Web of Science ®Google Scholar
• Gimbrone MA, Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci. 2000;902:230–239.
   PubMed Web of Science ®Google Scholar
• Huang PL. Endothelial nitric oxide synthase and endothelial dysfunction. Curr Hypertens Rep. 2003;5:473–480.
   PubMed Web of Science ®Google Scholar
• Sun X, Yu Y, Han L. High FFA levels related to microalbuminuria and uncoupling of VEGF-NO axis in obese rats. Int Urol Nephrol. 2013;45:1197–1207.
   PubMed Web of Science ®Google Scholar
• Gu P, Xu A. Interplay between adipose tissue and blood vessels in obesity and vascular dysfunction. Rev Endocr Metab Disord. 2013;14:49–58.
   PubMed Web of Science ®Google Scholar
• Van de Voorde J, Pauwels B, Boydens C, Decaluwe K. Adipocytokines in relation to cardiovascular disease. Metab Clin Exp. 2013;62:1513–1521.
   PubMed Web of Science ®Google Scholar
• Ross R. Atherosclerosis – an inflammatory disease. N Engl J Med. 1999;340:115–126.
   PubMed Web of Science ®Google Scholar
• Koh KK, Park SM, Quon MJ. Leptin and cardiovascular disease: Response to therapeutic interventions. Circulation. 2008;117:3238–3249.
   PubMed Web of Science ®Google Scholar
• Beltowski J, Jamroz-Wisniewska A, Wojcicka G, Lowicka E, Wojtak A. Renal antioxidant enzymes and glutathione redox status in leptin-induced hypertension. Mol Cell Biochem. 2008;319:163–174.
   PubMed Web of Science ®Google Scholar
• Lee MC, Chen YC, Ho GJ, Shih MH, Chou KC, Hsu BG. Serum leptin levels positively correlate with peripheral arterial stiffness in kidney transplantation patients. Transplant Proc. 2014;46:353–358.
   PubMed Web of Science ®Google Scholar
• Romero-Corral A, Sierra-Johnson J, Lopez-Jimenez F, et al. Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population. Nat Clin Pract Cardiovasc Med. 2008;5:418–425.
   PubMedGoogle Scholar
• Brennan AM, Li TY, Kelesidis I, Gavrila A, Hu FB, Mantzoros CS. Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: A prospective cohort study. Diabetologia. 2007;50:1178–1185.
   PubMed Web of Science ®Google Scholar
• Amrock SM, Weitzman M. Effect of increased leptin and C-reactive protein levels on mortality: Results from the National Health and Nutrition Examination Survey. Atherosclerosis. 2014;236:1–6.
   PubMed Web of Science ®Google Scholar
• Kimura K, Tsuda K, Baba A, et al. Involvement of nitric oxide in endothelium-dependent arterial relaxation by leptin. Biochem Biophys Res Commun. 2000;273:745–749.
   PubMed Web of Science ®Google Scholar
• Beltowski J, Wojcicka G, Borkowska E. Human leptin stimulates systemic nitric oxide production in the rat. Obes Res. 2002;10:939–946.
   PubMedGoogle Scholar
• Lembo G, Vecchione C, Fratta L, et al. Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes. 2000;49:293–297.
   PubMed Web of Science ®Google Scholar
• Ku IA, Farzaneh-Far R, Vittinghoff E, Zhang MH, Na B, Whooley MA. Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: the Heart and Soul Study. Atherosclerosis. 2011;217:503–508.
   PubMed Web of Science ®Google Scholar
• Basati G, Razavi AE, Abdi S, Sarrafzedegan N. Association of plasma leptin, homocysteine and nitric oxide levels with the presence and instability of coronary artery disease. Biomarkers Med. 2014;8:405–412.
   PubMed Web of Science ®Google Scholar
• Momin AU, Melikian N, Shah AM, et al. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance. Eur Heart J. 2006;27:2294–2299.
   PubMed Web of Science ®Google Scholar
• Vecchione C, Maffei A, Colella S, et al. Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. Diabetes. 2002;51:168–173.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002;13:134–141.
   PubMed Web of Science ®Google Scholar
• Komura N, Kihara S, Sonoda M, et al. Increment and impairment of adiponectin in renal failure. Cardiovasc Res. 2010;86:471–477.
   PubMed Web of Science ®Google Scholar
• Briley LP, Szczech LA. Leptin and renal disease. Semin Dial. 2006;19:54–59.
   PubMed Web of Science ®Google Scholar
• Cumin F, Baum HP, Levens N. Leptin is cleared from the circulation primarily by the kidney. Int J Obes Relat Metab Disord. 1996;20:1120–1126.
   PubMed Web of Science ®Google Scholar
• Morales JM, Marcem R, Andres A, et al. Renal transplantation in the modern immunosuppressive era in Spain: Four-year results from a multicenter database focus on post-transplant cardiovascular disease. Kidney Int. 2008;74:94–99.
   Web of Science ®Google Scholar
• Kocak H, Ceken K, Yavuz A, et al. Effect of renal transplantation on endothelial function in haemodialysis patients. Nephrol Dial Transplant. 2006;21:203–207.
   PubMed Web of Science ®Google Scholar
• Oflaz H, Pusuroglu H, Genchallac H, et al. Endothelial function is more impaired in hemodialysis patients than renal transplant recipients. Clin Transplant. 2003;17:528–533.
   PubMed Web of Science ®Google Scholar
• Locsey L, Seres I, Sztanek F, et al. Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients. Transplant Proc. 2013;45:3685–3687.
   PubMed Web of Science ®Google Scholar
• Turkmen K, Tonbul HZ, Toker A, et al. The relationship between oxidative stress, inflammation, and atherosclerosis in renal transplant and end-stage renal disease patients. Ren Fail. 2012;34:1229–1237.
   PubMed Web of Science ®Google Scholar
• Çankaya E, Bilen Y, Keles M, Uyanik A, Bilen N, Aydınlı B. Neutrophil-lymphocyte ratio is significantly decreased in preemptive renal transplant patients. Transplant Proc. 2015;47:1364–1368.
   PubMed Web of Science ®Google Scholar
• Idorn T, Hornum M, Bjerre M, et al. Plasma adiponectin before and after kidney transplantation. Transpl Int. 2012;25:1194–1203.
   PubMed Web of Science ®Google Scholar
• Colak H, Sert I, Kurtulmus Y, Karaca C, Toz H, Kursat S. The relation between serum testosterone levels and cardiovascular risk factors in patients with kidney transplantation and chronic kidney disease. Saudi J Kidney Dis Transpl. 2014;25:951–959.
   PubMedGoogle Scholar
• Chitalia N, Raja RB, Bhandara T, et al. Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation. J Nephrol. 2010;23:77–84.
   PubMed Web of Science ®Google Scholar
• Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int Suppl. 2003;85:105–110.
   PubMed Web of Science ®Google Scholar
• Bolton CH, Downs LG, Victory JG, et al. Endothelial dysfunction in chronic renal failure: Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001;16:1189–1197.
   PubMed Web of Science ®Google Scholar
• Malyszko J, Wolczynski S, Mysliwiec M. Adiponectin, leptin and thyroid hormones in patients with chronic renal failure and on renal replacement therapy: Are they related? Nephrol Dial Transplant. 2006;21:145–152.
   PubMed Web of Science ®Google Scholar
• Yilmaz A, Kayardi M, Icagasioglu S, Candan F, Nur N, Gultekin F. Relationship between serum leptin levels and body composition and markers of malnutrition in nondiabetic patients on peritoneal dialysis or hemodialysis. J Chin Med Assoc. 2005;68:566–570.
   PubMedGoogle Scholar
• Chudek J, Adamczak M, Karkoszka H, et al. Plasma adiponectin concentration before and after successful kidney transplantation. Transplant Proc. 2003;35:2186–2189.
   PubMed Web of Science ®Google Scholar
• Diez JJ, Iglesias P, Fernández-Reyes MJ, et al. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Clin Endocrinol (Oxf). 2005;62:242–249.
   PubMed Web of Science ®Google Scholar
• Tentolouris N, Doulgerakis D, Moyssakis I, et al. Plasma adiponectin concentrations in patients with chronic renal failure: Relationship with metabolic risk factors and ischemic heart disease. Horm Metab Res. 2004;36:721–727.
   PubMed Web of Science ®Google Scholar
• Adamczak M, Szotowska M, Chudek J, Karkoszka H, Cierpka L, Wieçek A. Plasma adiponectin concentration in patients after successful kidney transplantation-a single-center, observational study. Clin Nephrol. 2007;67:381–390.
   PubMed Web of Science ®Google Scholar
• Ambarkar M, Pemmaraju SV, Gouroju S, et al. Adipokines and their relation to endothelial dysfunction in patients with chronic kidney disease. J Clin Diagn Res. 2016;10:BC04–BC08.
   Google Scholar
• Guebre-Egziabher F, Bernhard J, Funahashi T, Hadj-Aissa A, Fouque D. Adiponectin in chronic kidney disease is related more to metabolic disturbances than to decline in renal function. Nephrol Dial Transplant. 2005;20:129–134.
   PubMed Web of Science ®Google Scholar
• Tsai JP, Leb MC, Chenc YC, Hoc GJ, Shihd MH, Hsub BG. Hyperleptinemia is a risk factor for the development of central arterial stiffness in kidney transplant patients. Transplant Proc. 2015;47:1825–1830.
   PubMed Web of Science ®Google Scholar
• El Haggan W, Chauveau P, Barthe N, Merville P, Potaux L, Aparicio M. Serum leptin, body fat, and nutritional markers during the six months post-kidney transplantation. Metab Clin Exp. 2004;53:614–619.
   PubMed Web of Science ®Google Scholar
• Nicoletto BB, Souza GC, Gonçalves LF, Costa C, Perry IS, Manfro RC. Leptin, insulin resistance, and metabolic changes 5 years after renal transplantation. J Ren Nutr. 2012;22:440–449.
   PubMed Web of Science ®Google Scholar
• Ribeiro S, Faria Mdo S, Silva G, et al. Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene. Hemodial Int. 2012;16:481–490.
   PubMed Web of Science ®Google Scholar
• Abe Y, Eto S, Matsumae T, et al. The proportion and metabolic effects of adiponectin multimeric isoforms in patients with chronic kidney disease on maintenance hemodialysis. Ren Fail. 2010;32:849–854.
   PubMed Web of Science ®Google Scholar
• Aiello S, Noris M, Remuzzi G. Nitric oxide/l-arginine in uremia. Miner Electrolyte Metab. 1999;25:384–390.
   PubMedGoogle Scholar
• Calo L, Davis P, Rigotti P, et al. ecNOS overexpression in CsA-treated renal transplant patients: Implications for CsA-induced hypertension. Transplant Proc. 1998;30:2012–2013.
   PubMed Web of Science ®Google Scholar
• Stojanovic D, Cvetkovic T, Stojanovic M, Bojanic V, Stefanovic N, Stojanovic I. The assessment of renalase: Searching for the best predictor of early renal dysfunction by multivariate modeling in stable renal transplant recipients. Ann Transplant. 2015;20:186–192.
   PubMed Web of Science ®Google Scholar
• Minz M, Heer M, Arora S, Sharma A, Khullar M. Oxidative status in stable renal transplantation. Transplant Proc. 2006;38:2020–2021.
   PubMed Web of Science ®Google Scholar
• Castillo RF, Garcia Rios MD, Pena Amaro P, Garcia Garcia I. Progression of alterations in lipid metabolism in kidney transplant recipients over 5 years of follow-up. Int J Clin Pract. 2014;68:1141–1146.
   PubMed Web of Science ®Google Scholar
• Ichimaru N, Takahara S, Kokado Y, et al. Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus. Atherosclerosis. 2001;158:417–423.
   PubMed Web of Science ®Google Scholar
• Spinelli GA, Felipe CR, Park SI, Mandia-Sampaio EL, Tedesco-Silva H, Jr, Medina-Pestana JO. Lipid profile changes during the first year after kidney transplantation: Risk factors and influence of the immunosuppressive drug regimen. Transplant Proc. 2011;43:3730–3737.
   PubMed Web of Science ®Google Scholar
• Kimak E, Bylina J, Solski J, Halabis M, Baranowicz-Gaszczyk I, Ksiazek A. Association between lipids, lipoproteins composition of HDL particles and triglyceride-rich lipoproteins, and LCAT and CETP activity in post-renal transplant patients. Cell Biochem Biophys. 2013;67:695–702.
   PubMed Web of Science ®Google Scholar
• Çolak H, Kilicarslan B, Tekce H, et al. Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients. Ther Apher Dial. 2015;19:56–62.
   PubMed Web of Science ®Google Scholar